Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its management will give an update on corporate progress at several intern...
Read moreLargest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundrostat in over 1,000 participants with uncontrolled or resistant hypertension in a real-world...
Read moreThe trial evaluated the safety and efficacy of ibrilatazar (ABTL0812) combined with paclitaxel/carboplatin in 40 patients with stage III/IV squamous non-small cell lung cancer (sq-NSCLC), at 6 leading...
Read moreAgitation/Aggression in PMS and other ASD-related patient subpopulations are the main focus of Oryzon’s VANDAM project included in the Med4Cure IPCEI project
Read moreTime matters for patients in need, and new research shows integrated services can reduce Phase I-III study times by up to nearly three years, generating strong ROI for biotech and biopharma customers ...
Read moreAnalytical method development in drug discovery refers to the process of designing, optimizing, and validating analytical techniques that can accurately characterize a drug candidate before it enters ...
Read moreLa XXV edición del Programa Farma-Biotech, que busca fomentar la investigación preclínica y traslacional, se ha centrado en esta ocasión en proyectos de Cataluña
Read moreImpurities in pharmaceuticals can compromise the safety, efficacy, and stability of a product. To safeguard public health, global regulatory authorities such as the International Council for Harmonisa...
Read moreThe study will evaluate the safety and efficacy of the molecule IMP1734, a selective inhibitor that blocks a key enzyme for DNA repair in cancer cells.
Read moreIn the RNA field, many companies are facing challenges when advancing research projects due to time, expertise, and resource constraints. Many biotechnology firms are seeking to overcome these hurdles...
Read moreIt has been today announced that they has received “Decision to grant” communications from the Canadian Intellectual Property Office and the Israel Patent Office for its patent applications CA3071...
Read moreEn sectores donde la pureza del ambiente es innegociable, como la industria farmacéutica, hospitales, laboratorios, electrónica y biotecnología, la contaminación cruzada representa una amenaza con...
Read more